We have developed and characterized cultures of healthy and dystrophic canine myoblasts for the evaluation of various gene transfer protocols. The number of desmin-positive myoblasts was elevated (>80%) in cultures of myoblasts obtained from different muscle territories, the diaphragm muscle giving rise to the purest cultures. Myoblasts from dogs turned out to be a very convenient source of well transfectable and transducible cells. Transfection with plasmid DNA allowed efficient transgene expression (50% of β-galactosidase positive cells and about 375 ng luciferase/mg protein after transfection with a calcium phosphate-precipitated plasmid). Infection with high concentrations of adenoviral and retroviral vectors allowed transgene (β-galactosidase or mini-dystrophin) detection in about 75 to 90% of the canine cells. Therefore, primary dog myoblast cultures represent a useful in vitro model for viral and non-viral gene delivery, as well as for functional evaluation and cell grafting with applications in genetic diseases, vaccination or production of circulating therapeutic proteins.
Introduction
Satellite cells (generally referred to as 'myoblasts') are quiescent mononuclear cells located between sarcolemma and basal lamina of adult skeletal muscle fibers (Mauro, 1961) . Upon activation, satellite cells allow muscle regeneration. Muscle satellite cell culture constitutes the model of choice to study myogenesis. Moreover, for a decade, myoblast cultures are also being used in the view of gene transfer. Cells can be isolated and made available in large number. They can be easily genetically modified in vitro and be injected back into muscles for autologous or heterologous transplantation. The unique biology of muscle cells allows the transplanted satellite cells to terminally differentiate and become part of myofibers by fusing to each other or by fusing with existing myofibers. Although considerable opitimization of these techniques is necessary, this approach has great potential benefits for tissue replacement as well as cellmediated gene therapy for systemic diseases such as primary myopathies, e.g. Duchenne Muscular Dystrophy (DMD), or deficiencies in circulating proteins, e.g. growth hormones or clotting factors (Grounds, 1996) .
Canine models are being used to evaluate gene transfer protocols aimed at new treatment of several diseases, such as enzyme deficiencies, i.e. canine mucopolysaccharidosis for deficiency of the lysosomal enzyme alpha-L-iduronidase (Shull et al., 1996) , myopathies, i.e. the Golden Retriever Muscular Dystrophy (GRMD) and X-linked Muscular Dystrophy (XMD) dogs for DMD (Howell et al., 1997; Cooper et al., 1988) , hyperkaliemic periodic paralysis (Jezyk, 1982) , malignant hyperthermia (Nelson, 1991) , or hemophilia (Brinkhous, 1992) . Different gene transfer strategies using viral and non-viral vectors, as well as cell graft, engineered muscle satellite cell transplantation (Cooper, 1990) or microencapsulated cell (Peirone et al., 1998) transplantation, can be evaluated in those dog models with implications for treatment of myopathies, cardiomyopathy, cardiomyoplasty (Chiu et al., 1995) , hormone or enzyme deficiencies (Ferrara et al., 1997) . GRMD or XMD dogs are excellent clinical models for the study of gene therapy in dystrophin deficient myopathies (Kornegay, 1992) . There are many similarities between affected dogs and DMD patients, including muscle atrophy with contractures, histologically prominent muscle necrosis, degeneration with mineralisation (with calcification particularly evident in the diaphragm), and concurrent regeneration and cardiomyopathy (Valentine et al., 1992) . XMD and GRMD dogs lack the dystrophin protein which characterizes the muscle changes as in the case of DMD. Affected dogs may die within days or years of birth. Preliminary gene therapy experiments with the full length or the mini-dystrophin gene were performed with intramuscular injections of either adenoviral or plasmid vectors (Howell et al., 1997 (Howell et al., , 1998 .
We have developed and characterized cultures of healthy and dystrophic canine myoblasts for the evaluation of various gene transfer protocols. Such myoblasts turned out to be a very convenient source of well transfectable and transducible cells. We have thus evaluated different means of introducing cDNA into canine myoblasts.
Material and Methods

Primary satellite cells (myoblasts)
Muscle cultures were established from satellite cells of portions of muscle biopsies from 6 to 8 monthold healthy or GRMD dogs, or from human patients free of metabolic diseases, according to a technique described previously (Askanas and Engel, 1975; Askanas and Gallez-Hawkins, 1985) . Cells were harvested from explant cultures and grown at 37 • C in a humidified atmosphere (5% CO 2 ), in Ham's F14 medium (Life Technologies, Cergy-Pontoise, France) supplemented with 10% fetal calf serum (Hyclone, Logan, UT, USA), 10 µg/ml insulin, 10 ng/ml epidermal growth factor (both from Sigma-Aldrich, L'Isle d'Abeau Chesne, France), 10 ng/ml basic fibroblast growth factor (Pepro Tech, Rocky Hill, NJ, USA), 2 mM glutamine (bioMérieux, Marcy l'Etoile, France) and 40 µg/ml gentamicin (Schering Plough, Kenilworth, NJ, USA). When cells reached confluency, myoblasts fused and formed multinucleated myotubes. In our conditions the ability of the dog myoblasts to fuse was lost after few subcultures. Experiments were performed on myoblasts obtained after a maximum of 12 passages and seeded (10,000/cm 2 ) on 0.1% gelatincoated supports. Culture supports were either 96, 24 or 6 microwell-plates (Falcon , Becton Dickinson, Franklin Lakes, NJ) depending on the experimental design. The 'muscle' character of the primary cells was determined by immunocytochemistry for desmin, dystrophin and their ability to fuse to form myotubes.
Vectors
Plasmids: the plasmids used for the transfection experiments were: -pTG11033 and pTG11025 were E. coli plasmids, based on the ColE1 origin of replication, and included the Tn903 gene which confers kanamycin resistance. They carried an expression cassette encoding either (pTG11033) the fire-fly luciferase (Manthorpe et al., 1993) or (pTG11025) the fulllength dystrophin cDNA driven by the human cytomegalovirus IE1 promoter (from pCEP4, InVitrogen, Abingdon, UK). The first mouse HMGCR intron (Gautier et al., 1989) was cloned immediately upstream from the encoding sequence for the reporter gene, and a SV40 polyadenylation signal sequence was inserted downstream to the gene. -pCH110N, generously provided by Prof. Pierre Chambon (IGBMC, Strasbourg, France), was derived from pCH110. pCH110N carried the lacZ gene (Hall et al., 1983 ) with a nuclear localization signal and under the control of the early promoter of SV40. Plasmid DNA was amplified in E. coli strain MC1061 by overnight culture in LB medium (OD 600 ≈ 2.5) and purified by double CsCl gradient centrifugation after alkaline lysis according to standard techniques (Sambrook et al., 1989) . Purified plasmid DNA was concentrated to 1 mg/ml in 10mM Tris, 1 mM EDTA, pH 7.5.
Synthetic vectors: when Lipofectin, a mixture of DOTMA and DOPE, 1/1 (Life Technologies, CergyPontoise, France) was used, complexes were prepared according to the manufacturer's recommendations and at a weight/weight ratio of 4 lipofectin / 1 DNA, and diluted in PBS. The suspension was added to cells cultured in 96 well-plates (50 µl/0.5µg DNA/well). After 4 hrs transfection, 150 µl of culture medium/well was added, and medium was replaced with 150 µl fresh medium after 24 hrs.
Synthesis of spermidine-cholesterol or DC-Cholesterol and preparation of DNA/lipid complexes (charge ratio 1/1) were performed as described elsewhere (Bischoff et al., 1997) .
All transfections were performed in the presence of DOPE, since activities dimished significantly when using the cationic lipid alone (Gao and Huang, 1991) .
Adenovirus: Recombinant E1/E4 deleted adenoviruses were obtained as described (Lusky et al., 1998) . Two adenoviruses were generated: AdTG5621 (RSV promoter, β-globin intron) and AdTG5653 (CMV promoter) carried the mini-dystrophin expression cassette generously provided by K.E. Davies (Acsadi et al., 1991) .
Rescue of pure viral particules was performed in complementing human embryonic kidney 293 cell lines and purified as described (Lusky et al., 1998; Graham and Prevec, 1991) . Adenovirus RSV-β-galactosidase (AdRSVβgal) was kindly provided by M. Perricaudet (Stratford-Perricaudet et al., 1992) .
Retrovirus: Retrovirus vector TG 5391 carried the E. coli β-galactosidase (lacZ) gene under control of the LTR, and the puromycin N-acetyl transferase gene (Vara et al., 1985) under control of the internal SV40 early promoter (manuscript in preparation). The vector was produced in amphotropic human E17 packaging cells which were generated from the 293 cell line (Graham et al., 1977) . The packaging cells stably express FMuLV (strain FB29) gag/pol genes (Sitbon M et al., 1986) and an amphotropic envelop gene derived from pPAM3, kindly provided by A.D. Miller (Fred Hutchinson Cancer Research Center, Seattle, WA, USA). Cells were grown in Dulbecco's modified Eagle's medium containing 10% (vol/vol) fetal calf serum, 3 g/L glucose, 1% non-essential amino acids and 200µg/ml gentamycin. Plasmid pTG 5391 was transfected into E17 cells by calcium phosphate precipitation (Graham and van der Eb, 1973) . Stably transfected cells were selected in medium containing 1 µg/ml puromycin. Individual cell clones were isolated and the vector titer was determined on NIH 3T3 cells using standard methods. In brief, 24 h-cell culture supernatant was recovered and filtered through 0.45 µm filters. 5 × 10 5 3T3 cell in 6-well plates were incubated for 1 h in presence of 8 µg/ml polybren with 400 µl of 10-fold serial dilutions of supernatants from stably transfected producer cell clones. After 1 h, 2 ml of medium was added. 24 h later, medium was replaced by polybren-free medium. In duplicate wells, 48 h after the infection, β-galactosidase expressing transduced cells were determined as described by Sanes et al., (1986) . Cells were fixed in formaldehyde/glutaraldehyde and stained with X-Gal. The producer cell clone finaly retained gave a titer of 1.8 × 10 7 cfu/ml.
Gene transfer procedures
Calcium phosphate transfection: transfections were performed according to the standard protocol (Graham and Van der Eb, 1973) on cells 3 days after seeding, using 0.5, 2 or 1 µg/well of respectively 96 (5 × 10 3 cells per well), 24 well-plates (10 5 cells per well) or 8 well-Lab-Tek tissue culture chambers (5 × 10 3 cells per well). Depending on the culture plate, culture medium was replaced by fresh medium mixed with respectively 10 µl, 100 µl or 300 µl of calcium phosphate-precipitated plasmid.
Transductions: adenovirus vectors were added to the cells at various multiplicities of infection (MOI) (ranging from 5 to 10, 100 and 500 IU/cell) in 100 µl PBS buffer. After 30 min incubation at 37 • C in 5% CO 2 , 1 ml of culture medium was added in each well.
For retrovirus TG5391, cells were infected with 200 µl of serial dilutions of vector. After 1h, 1.6 ml of culture medium was added.
Unless specified otherwise, cells were harvested for luciferase activity, or fixed for β-galactosidase or dystrophin 48 h after transfection.
Parameters analysed
Luciferase assay: cultures were washed once with PBS buffer. Extraction of luciferase from cell layers was then performed according to Manthorpe et al. (1993) with 50 µl (96 well-plates) or 100µl (24-well plates) of lysis buffer (Promega, Madison, WI, USA) per well. 10 to 20 µl of samples were analyzed using the Luciferase Assay System (Promega) in 96-well microtiter plates in a luminometer (Berthold LB96P, EG&G Instruments, Evry, France). Values are given in relative light units (RLU) per minute for each well and substracted from background values (around 800 RLU/min with empty wells or cell seeded-wells). Calibration of the luminometer with purified luciferase gave a linear range from 100 fg to 1 ng corresponding to 2 × 10 3 to 5 × 10 7 RLU/min. β-galactosidase staining: cells were fixed with 2% formaldehyde/0.2% glutaraldehyde in PBS for 10 min at 4 • C, and stained in a standard manner (MacGregor et al., 1991) .
Immunocytochemistry: Cultures were fixed 5 min with cold (-20 • C) methanol/acetone (1/1). Minidystrophin detection was performed using the dystrophin-specific antibody Mandra-1 (directed against the C-teminus part of dystrophin) or Mandys-8 (directed against the central part of the dystrophin, thus not recognizing mini-dystrophin). Detection was obtained using a secondary rabbit anti-mouse IgG (Dako, Glostrup, Denmark) followed by incubation with an FITC-labeled mouse anti-rabbit IgG antibody (Sanofi Diagnostics Pasteur, Marnes-la-Coquette, France). Antibody dilutions were 1/100. Incubations times were 45 min at room temperature.
Electrophoresis and Western blot:
Cultures were rinsed in ice-cold PBS and solubilised by addition of the Sample Treatment Buffer described by Nicholson et al. (1989) with mercaptoethanol being replaced by 100 mM dithiothreitol and without bromophenol blue. Samples were boiled for 3 min at 100 • C passed through a 1-ml needle to break DNA and centrifuged at 10,000 × g for 5 min at room temperature. Soluble fractions were stored at -80 • C until analysis. Protein concentrations were determined according to Pande and Murthy (1994) . Protein samples were separated by SDS-PAGE on 4-12% polyacrylamide gels (Novex, San Diego, CA) and transferred to nitrocellulose (50 V) for 3-5 h using a wet-transfer apparatus (Hoefer, San Francisco, CA) in 50 mM Tris, 380 mM glycine, 0.01% (w/v) SDS transfer buffer. Nitrocellulose sheets were saturated with 5% non-fat dry milk in TBST and incubated for 100 min with monoclonal antibodies against the central rod domain or the Cterminal part of dystrophin (NCL-DYS1, NCL-DYS2, Novocastra, Newcastle, UK), at 1/200 and 1/100 dilutions respectively. After washing, membranes were probed with HRP-conjugated anti-mouse antibodies (Dako) at a 1/5000 dilution for 1 h and developed using the ECL chemiluminescence system (Amersham, Buckinghamshire, UK). Figure 1 shows primary cultures of dog myoblasts. The purity of the primary cultures was assessed by immunodetection of desmin, a specific cytoskeletal marker of muscle cells. In all cases, myoblasts appeared as fusiform mononucleated cells. Contaminating cells with a flat multiform morphology were also found. Under our conditions the number of desminpositive myoblasts was elevated (>80%, while in our experience human myoblast cultures had more variable proportions of myoblast/non-myoblast cells. In the case of cultures from dogs differences were found among muscle, the diaphragm muscles giving rise to the purest cultures. In contrast, quadriceps led to less myoblastic cultures. Even though no systematic measurements were performed we noticed that, in contrast to human muscle cells, the ability to fuse of canine myoblasts was reduced during subculturing but the cells retained an elevated proliferation rate (doubling time did not exceed 36 h) even in low serum conditions (2%). Based on the cell morphology and desmin staining, we found that up to 15 passages could be performed without alteration of the myoblast phenotype. This allowed production of large amount of cells (about 10 11 to 10 13 cells) from only milligrams of muscle biopsies.
Results and discussion
The anatomic origin of the muscle samples could influence culture parameters. We noticed that diaphragm muscles gave lower cell yields (less outgrowth from muscle explants) than other muscles, but better myoblast/non-myoblast ratio.
Storage of canine muscle biopsy samples at 4 • C for several days did not allow both higher cell yields and better fusion rates (data not shown) in contrast to what we routinely observe for human muscle cultures (also described in Bonavaud et al., 1997) .
Transfection with plasmid DNA allowed efficient transgene expression. As shown in Figure 2A , about 50% of pCH110N-transfected dog myoblasts stained positive for β-galactosidase. As also indicated in Figure 3 , luciferase expression of canine myoblasts transfected with 1µg/well of calcium phosphate-precipitated pTG11033 was 1.2 ± 0.65 × 10 9 RLU/min/well of 96-well plates (5 independent experiments), which corresponds to approximately 3.7 ng luciferase per well (0.03% of total proteins). Such values are similar to those of cell lines such as A549 cells (Bischoff et al., 1997) . No differences in gene transfer efficiency between healthy and dystrophic dog myoblasts were found (not shown). In our hands, dog myoblasts displayed much higher luciferase activities than human myoblast cultures. Using 0.5 µg calcium phosphate-precipitated pTG11033 under similar conditions, we found approximately 375 ± 98 and 14 ± 4 ng luciferase/mg proteins in dog (n=5) and human myoblast cultures (n=15) respectively. This may reflect a higher number of transfected dog cells since based also on transfections with lacZ expressing-plasmid only very few (less than 0.1%) human myoblasts stained positive, whereas up to 50% of the canine myoblasts were positive.
Synthetic cationic lipids consist in general of a cationic, hydrophilic head group (e.g., spermidine) and a hydrophobic tail (e.g., fatty acid). Most of the molecules are formulated together with the zwitterionic phospholipid dioleoyl-phosphatidylethanolamine (DOPE) to enhance transfection. Differences in efficiency among cationic lipids have been reported depending on the cell type and the ratio between lipid and DNA (Felgner et al., 1994 , Bischoff et al., 1997 . In a more detailed study (Bischoff et al., 1997) , we found that slight structural differences between cationic lipids led to significantly different transfection efficiencies for myoblasts in primary cultures, with implications for cell or organ targeting.
As summarized in Table 1 , synthetic vectors such as spermidine-cholesterol-DOPE or lipofectin complexed to pTG11033 at the optimal charge ratio of 1 allowed stronger transfection efficiencies of canine myoblasts (111 ± 49, ng luciferase/mg pro- Cultures were grown in 96 well-plates and transfection were performed with 0.5 µg of pTG11033 luciferase plasmid. Values are ng luciferase per mg proteins. n: number of independent experiments. Luciferase activity was determined 2 days after transfection.
teins, n=3, and 38 ng luciferase/mg proteins, n=1, respectively) than human myoblasts (1 and 2.5 ng luciferase/mg proteins). These values combined with our Western blot analysis (Figure 4 ) indicate that transgene expression levels were slightly (spermidinecholesterol-DOPE vector) or significantly (lipofectine and DC-cholesterol-DOPE vectors) lower with synthetic vectors as compared to the calcium phosphate method.
As indicated in Figure 2B (adenovirus expressing β-galactosidase), Figure 2C (retrovirus expressing β-galactosidase), Figure 2D (adenovirus expressing mini-dystrophin), Figure 4 (right Western blot, minidystrophin) (specificity for mini-dystrophin was verified using a monoclonal antibody directed to the central part of the protein -antibody Mandys8-being therefore unable to recognize mini-dystrophin -not shown-) and in Table 2 , transductions with viral vectors were very efficient. About 75 to 90% of the dog myoblasts displayed detectable transgene (β-galactosidase or mini-dystrophin) expression with adenoviral vectors. Around 60% of the dog myoblasts infected with retrovirus expressed the β-galactosidase transgene and without selection with antibiotics. However, high viral titers were needed to obtain high efficiency of transduction. A similar efficiency was found with a retrovirus-β-galactosidase LNPOZ by Ito et al. (1998) , though after neomycin selection. Nevertheless, only limited comparison is allowed since no indications on constructs and titers were given by the authors.
Based on microscopic examination of the cell morphology and proliferation rate and of the myoblast ability to fuse during the culture days following transfection, we observed that, as for other cell types, some toxicity can be found at the highest concentrations Proportion of β-galactosidase-positive myoblasts after infection with viral vectors. Canine myoblast cultures were grown in 6 well-plates (3 wells per condition). β-galactosidase staining was performed on glutaraldehyde-fixed cultures 2 days after transduction with either adenovirus (AdRSVbgal) or retrovirus (pTG5391) vectors. Cells were counted using a bright field microscope (5 fields per well). Values are mean ± sem.
of calcium phosphate-precipitated or cationic lipid complexed plasmid used. Canine myoblasts division seemed to be slowered at adenovirus MOI exceeding 500. On the other hand, at the highest retrovirus particule concentration used, no obvious change in morphology, proliferation rate or differentiation was seen in both dog and human myoblast infected cultures. In all cases, no differences in gene transfer efficiency were observed between healthy and dystrophic dog myoblasts, healthy and DMD human myoblasts or C57BL/10 and mdx myoblasts (not shown).
In summary, the present study shows that primary canine myoblasts can be efficiently transfected with different types of vectors (precipitated plasmid, synthetic vectors and viruses). Efficiency of transfer was greatest when using viral vectors and with calcium phopshate. Such cultures represent a useful in vitro model for evaluation of viral and non viral gene vectors. These cell cultures can also be used for studies of cell grafts aimed at muscle-targeted ex vivo gene therapy for applications in humans such as muscle dystrophy (Grounds, 1996) , vaccination, production of therapeutic circulating factors or for cellular cardiomyoplasty (Chiu et al., 1995) . tors and adenoviruses, and K.E. Davies for the minidystrophin cDNA. This work was presented at the 15th ESACT Meeting, Tours Sept 7/11 1997.
